Molecular epidemiology of recent United Kingdom isolates of Neisseria meningitidis serogroup C.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 2271220)

Published in Epidemiol Infect on August 01, 1994

Authors

D E Yakubu1, F J Abadi, T H Pennington

Author Affiliations

1: Department of Medical Microbiology, University of Aberdeen Medical School, Foresterhill.

Articles cited by this

A physical map of the Escherichia coli K12 genome. Science (1987) 8.42

Resolution of recent evolutionary divergence among Escherichia coli from related lineages: the application of pulsed field electrophoresis to molecular epidemiology. J Infect Dis (1990) 8.33

Restriction endonucleases for pulsed field mapping of bacterial genomes. Nucleic Acids Res (1987) 7.03

Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci U S A (1986) 5.39

Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J Bacteriol (1987) 5.30

Genome organization of the anaerobic pathogen Clostridium perfringens. Proc Natl Acad Sci U S A (1989) 4.21

Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis. J Infect Dis (1993) 4.02

Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983. Rev Infect Dis (1988) 3.28

Subtyping of Neisseria gonorrhoeae auxotype-serovar groups by pulsed-field gel electrophoresis. J Med Microbiol (1993) 3.04

Applications of restriction endonuclease fingerprinting of chromosomal DNA of Neisseria meningitidis. J Clin Microbiol (1984) 2.91

Analysis of the clonal relationships between strains of Neisseria meningitidis by pulsed field gel electrophoresis. J Gen Microbiol (1992) 2.58

Pulsed field gel electrophoresis as a new epidemiological tool for monitoring methicillin-resistant Staphylococcus aureus in an intensive care unit. J Hosp Infect (1991) 2.49

Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J Clin Microbiol (1991) 2.38

Epidemiologic and clinical utility of typing systems for differentiating among strains of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (1991) 2.09

Genetic relationships and clonal population structure of serotype 2 strains of Neisseria meningitidis. Infect Immun (1987) 2.04

Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986. J Infect Dis (1990) 1.96

Characterization of Neisseria meningitidis isolated by ribosomal RNA gene restriction patterns and restriction endonuclease digestion of chromosomal DNA. Epidemiol Infect (1991) 1.89

Characterization of Neisseria meningitidis serogroup C by multilocus enzyme electrophoresis and ribosomal DNA restriction profiles (ribotyping). J Clin Microbiol (1992) 1.49

Meningococcal disease in the United States--1986. Meningococcal Disease Study Group. J Infect Dis (1991) 1.34

An epidemiologically valuable typing method for Neisseria meningitidis by analysis of restriction fragment length polymorphisms. J Med Microbiol (1991) 1.02

Comparison of clonal analysis and DNA restriction analysis for typing of Neisseria meningitidis. Microb Pathog (1988) 1.02

Meningococcal disease. J Med Microbiol (1993) 1.00

Chemoprophylaxis of bacterial meningitis. J Antimicrob Chemother (1993) 0.95

Genetic relationships among strains of Neisseria meningitidis causing disease in Italy, 1984-7. Epidemiol Infect (1991) 0.91

Meningococcal infections in England and Wales: 1992. Commun Dis Rep CDR Rev (1993) 0.85

A NheI macrorestriction map of the Neisseria meningitidis B1940 genome. FEMS Microbiol Lett (1993) 0.82

Articles by these authors

Differentiation of staphylococcal species and strains by ribosomal RNA gene restriction patterns. J Gen Microbiol (1989) 2.08

Vaccinia virus polypeptide synthesis: sequential appearance and stability of pre- and post-replicative polypeptides. J Gen Virol (1974) 1.97

Characterization of Neisseria meningitidis isolated by ribosomal RNA gene restriction patterns and restriction endonuclease digestion of chromosomal DNA. Epidemiol Infect (1991) 1.89

Vaccinia virus replication in enucleate BSC-1 cells: particle production and synthesis of viral DNA and proteins. J Virol (1974) 1.72

Molecular characterization of rifampin-resistant Neisseria meningitidis. Antimicrob Agents Chemother (1994) 1.70

Hepatitis Bs antibody in alcoholic cirrhosis. J Clin Pathol (1979) 1.61

Virulence in Newcastle disease virus. A preliminary study. Br Med Bull (1967) 1.55

Virus development in enucleate cells: echovirus, poliovirus, pseudorabies virus, reovirus, respiratory syncytial virus and Semliki Forest virus. J Gen Virol (1975) 1.49

Molecular typing of Toxoplasma gondii strains by GRA6 gene sequence analysis. Int J Parasitol (2000) 1.48

Staphylococcal whole-cell polypeptide analysis: evaluation as a taxonomic and typing tool. J Med Microbiol (1987) 1.33

Population genetics of Mycobacterium tuberculosis complex in Scotland analysed by pulsed-field gel electrophoresis. Epidemiol Infect (1995) 1.28

Molecular epidemiology of Escherichia coli O157:H7 by pulsed-field gel electrophoresis and comparison with that by bacteriophage typing. J Clin Microbiol (1996) 1.27

Allelic variation in the Helicobacter pylori flagellin genes flaA and flaB: its consequences for strain typing schemes and population structure. Epidemiol Infect (1995) 1.21

Clonal structure of invasive Streptococcus pyogenes in Northern Scotland. Epidemiol Infect (1995) 1.20

Epidemiological evaluation of Neisseria meningitidis serogroup B by pulsed-field gel electrophoresis. FEMS Immunol Med Microbiol (1995) 1.20

The use of a nested polymerase chain reaction for detecting Pneumocystis carinii from lung and blood in rat and human infection. J Med Microbiol (1995) 1.19

Bunyamwera virus-induced polypeptide synthesis. J Virol (1977) 1.18

Characterisation of methicillin-resistant isolates of Staphylococcus aureus by analysis of whole-cell and exported proteins. J Med Microbiol (1989) 1.17

Typing of strains of Staphylococcus aureus by Western Blot analysis of culture supernates. J Med Microbiol (1986) 1.14

Rifampin resistance in Neisseria meningitidis due to alterations in membrane permeability. Antimicrob Agents Chemother (1996) 1.14

The Hippocratic oath. Is not administered in the strictly legal sense. BMJ (1994) 1.11

Molecular typing methods for Neisseria meningitidis. J Med Microbiol (1999) 1.10

Events in vaccinia virus-infected cells following the reversal of the antiviral action of rifampicin. J Gen Virol (1970) 1.10

Specificity and usefulness of an IgE immunosorbent agglutination assay for toxoplasmosis. J Clin Pathol (1995) 1.08

Improved diagnosis of reactivated toxoplasmosis. Mol Pathol (1998) 1.07

Intergenic spacer (IGS) polymorphism: a new genetic marker for differentiation of Toxoplasma gondii strains and Neospora caninum. J Parasitol (2000) 1.04

Temporal study of staphylococcal species on the skin of human subjects in isolation and clonal analysis of Staphylococcus capitis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Microbiol (1989) 1.03

Variation in length and sequence of porin (ompP2) alleles of non-capsulate Haemophilus influenzae. Mol Microbiol (1992) 1.02

Long-term survival of Escherichia coli O157 on pasture following an outbreak associated with sheep at a scout camp. Lett Appl Microbiol (2002) 1.02

The effect of monensin on virion production and protein secretion in pseudorabies virus-infected cells. J Gen Virol (1984) 0.99

Genetic heterogeneity of M type 3 group A streptococci causing severe infections in Tayside, Scotland. J Clin Microbiol (1996) 0.99

Do IgA, IgE, and IgG avidity tests have any value in the diagnosis of toxoplasma infection in pregnancy? J Clin Pathol (1998) 0.96

Vaccinia virus morphogenesis: a comparison of virus-induced antigens and polypeptides. J Gen Virol (1973) 0.96

Antimicrobial susceptibility of penicillin-sensitive and penicillin-resistant meningococci. J Antimicrob Chemother (1995) 0.95

Haemophilus influenzae subtyping by SDS-PAGE of whole-cell polypeptides. Epidemiol Infect (1987) 0.93

Characterization of coagulase-negative staphylococci by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot analyses. J Clin Microbiol (1989) 0.92

Isatin-beta-thiosemicarbazone causes premature cessation of vaccinia virus-induced late post-replicative polypeptide synthesis. J Gen Virol (1977) 0.92

Methicillin susceptibility testing of staphylococci by Etest and comparison with agar dilution and mecA detection. J Antimicrob Chemother (1997) 0.90

Events following the infections of enucleate cells with measles virus. J Gen Virol (1976) 0.88

Inhibition of poxvirus maturation by rifamycin derivatives and related compounds. J Virol (1971) 0.87

Western blot analysis of staphylococcal antibodies present in human sera during health and disease. J Med Microbiol (1987) 0.86

Processing of a pseudorabies virus-induced protein which is glycosylated, sulphated and excreted. J Gen Virol (1977) 0.86

Incidence and spread of Haemophilus influenzae on an Antarctic base determined using the polymerase chain reaction. Epidemiol Infect (1995) 0.83

Rapid methods in bacterial DNA fingerprinting. J Gen Microbiol (1991) 0.83

The role of a nested polymerase chain reaction in the diagnosis of Pneumocystis carinii pneumonia. Clin Mol Pathol (1995) 0.83

HIV induces modulation of functionally important cellular antigens. Clin Exp Immunol (1991) 0.82

Usefulness of rat-derived antigen in the serodiagnosis of Pneumocystis carinii infection. J Med Microbiol (1999) 0.81

Characterization of enterococcal isolates by restriction enzyme analysis of genomic DNA. Epidemiol Infect (1992) 0.81

An analysis of the diversity of Haemophilus parainfluenzae in the adult human respiratory tract by genomic DNA fingerprinting. Epidemiol Infect (1993) 0.81

The population structure and transmission of Escherichia coli in an isolated human community; studies on an Antarctic base. Epidemiol Infect (1991) 0.81

Clonal analysis of non-typable Haemophilus influenzae by sodium dodecyl sulphate-polyacrylamide gel electrophoresis of whole cell polypeptides. J Med Microbiol (1991) 0.81

Ocular vaccinia. Lancet (1974) 0.81

Molecular systematics and traditional medical microbiologists--problems and solutions. J Med Microbiol (1994) 0.80

The detection of penicillin insensitivity in Neisseria meningitidis by polymerase chain reaction. J Antimicrob Chemother (1998) 0.80

Specific secretion of polypeptides from cells infected with vaccinia virus. J Virol (1978) 0.79

Antiviral effect of constituent parts of the rifampicin molecule. Nature (1971) 0.79

The value of Toxoplasma specific IgA in diagnosis. J Clin Pathol (1995) 0.79

Does Paget's disease really have a viral aetiology? J Bone Miner Res (1997) 0.78

Infectious mononucleosis, herpes simplex infection, and diffuse lymphoma in a renal transplant recipient. Transplantation (1978) 0.77

Antigenic differences between strains of Newcastle disease virus. Arch Virol (1978) 0.77

The inhibition of variola minor virus multiplication by rifampicin. Arch Gesamte Virusforsch (1970) 0.77

Effect of rifamycins and related antibiotics on the deoxyribonucleic acid-dependent ribonucleic acid polymerase of vaccinia virus particles. J Virol (1971) 0.75

Differences exist in the immunoblotting profiles of cyst and trophozoite antigens of Pneumocystis carinii. J Med Microbiol (1995) 0.75

Is Bordetella pertussis clonal? BMJ (1992) 0.75

Lyme borreliosis. Lancet (1994) 0.75

Management of medical research. Open up the evaluation process. BMJ (1993) 0.75

Effect of 5-bromodeoxyuridine on vaccinia virus-induced polypeptide synthesis: selective inhibition of the synthesis of some post-replicative polypeptides. J Virol (1976) 0.75

The diagnosis of Lyme disease. J R Soc Med (1995) 0.75

The bacteria craze. Lancet (1999) 0.75

In vitro activities of meropenem and other antimicrobial agents against British meningococcal isolates. Chemotherapy (1999) 0.75

Influenza. Scott Med J (2008) 0.75

Specific secretion of polypeptides from cells infected with myxoma virus. J Gen Virol (1982) 0.75

Escherichia coli O157 in abattoirs. Lancet (1997) 0.75

Protease activation of Sendai virus infectivity; studies in non-permissive and permissive cells. J Gen Virol (1978) 0.75

The microbiological safety of food. J Med Microbiol (2000) 0.75

Study of the immunogenicity of trivalent inactivated whole-virion influenza vaccine in human volunteers. J Biol Stand (1982) 0.75

A direct effect of some rifamycin derivatives on the morphology of mammalian mitochondria. Exp Cell Res (1973) 0.75

Progression of Pneumocystis carinii infection in an animal model. J Med Microbiol (1998) 0.75

Absorption of IgG does not enhance toxoplasma IgM and IgA immunoblotting. J Med Microbiol (1999) 0.75

Functional heterogeneity of CBL-1 and HTLV-IIIB. Lancet (1991) 0.75

Letter: Rapid diagnosis of virus infections. Lancet (1975) 0.75

A simple dark ground method for the recording of gel diffusions. (Brief report). Arch Gesamte Virusforsch (1965) 0.75